The year in cardiology: heart failure 2014

Eur Heart J. 2015 Feb 14;36(7):421-4. doi: 10.1093/eurheartj/ehu503. Epub 2015 Jan 8.

Authors

Adriaan A Voors¹, Frank Ruschitzka²

Affiliations

¹ Department of Cardiology, AB31, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen 9713 GZ, The Netherlands a.a.voors@umcg.nl.
² Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland.

PMID: 25575601
DOI: 10.1093/eurheartj/ehu503

No abstract available

MeSH terms

Adrenergic beta-Antagonists / therapeutic use
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Cardiac Resynchronization Therapy
Cardiotonic Agents / therapeutic use
Epigenomics / trends
Forecasting
Heart Failure / therapy*
Humans
Infusions, Intravenous
Iron / administration & dosage
Mineralocorticoid Receptor Antagonists / therapeutic use
Randomized Controlled Trials as Topic
Recombinant Proteins / therapeutic use
Relaxin / therapeutic use
Renin-Angiotensin System / drug effects
Spironolactone / therapeutic use
Stroke Volume / physiology
Telemedicine / statistics & numerical data
Vagus Nerve Stimulation / statistics & numerical data

Substances

Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors
Cardiotonic Agents
Mineralocorticoid Receptor Antagonists
Recombinant Proteins
serelaxin protein, human
Spironolactone
Relaxin
Iron